Prime Medicine, Inc. (PRME) Return on equity 2020–2025
Prime Medicine, Inc. (PRME) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-166.4%FY2025 · since FY2020: -145.9% → -166.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -166.4% | -38.5 pp |
| FY2024 | -127.9% | +21.0 pp |
| FY2023 | -148.9% | -110.4 pp |
| FY2022 | -38.5% | — |
| FY2020 | -145.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice